Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization SFA Therapeutics, Inc.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
SARS-CoV-2 acute respiratory disease | Phase 3 | US | SFA Therapeutics, Inc.Startup | 09 May 2020 |
Acute Myeloid Leukemia | Phase 1 | - | SFA Therapeutics, Inc.Startup | - |
Acute Myeloid Leukemia | Phase 1 | - | - | |
Chronic Lymphocytic Leukemia | Phase 1 | - | - | |
Chronic Lymphocytic Leukemia | Phase 1 | - | SFA Therapeutics, Inc.Startup | - |
Liver Cancer | Phase 1 | - | - | |
Liver Cancer | Phase 1 | - | SFA Therapeutics, Inc.Startup | - |